These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15368170)

  • 21. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course.
    Cortez-Pinto H; Camilo ME
    Best Pract Res Clin Gastroenterol; 2004 Dec; 18(6):1089-104. PubMed ID: 15561640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alcoholic and non-alcoholic fatty liver hepatitis. When is abstaining from alcohol enough, when do steroids help?].
    Berghaus TM; Beuers U
    MMW Fortschr Med; 2001 Jul; 143(26-27):28-32. PubMed ID: 11481912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alcoholic and nonalcoholic steatohepatitis: the same disease! II. Management].
    Spahr L; Hadengue A
    Rev Med Suisse; 2005 Sep; 1(31):2032-4. PubMed ID: 16212005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nonalcoholic steatohepatitis: a clinicopathological analysis of liver biopsy in 32 cases].
    Meng JR; Zheng RD; Zhang MF; Guo YH; Lin MZ; Dai TJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):339-41. PubMed ID: 16546742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alcoholic and non-alcoholic steatohepatitis: who is affected and what can we do for them?].
    Gallego-Durán R; Ampuero J; Funuyet J; Romero-Gómez M
    Gastroenterol Hepatol; 2013 Nov; 36(9):587-96. PubMed ID: 24011648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS; Helzberg JH; Nachnani JS; Gurram K
    Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic steatohepatitis.
    Jansen PL
    Neth J Med; 2004; 62(7):217-24. PubMed ID: 15554595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Jansen PL
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Systemic lupus erythematosus with steroid induced non-alcoholic steatohepatitis: a case report].
    Kamata Y; Kamimura T; Yoshio T; Hirata D; Masuyama J; Isoda N; Kanai N; Minota S
    Ryumachi; 2003 Oct; 43(4):667-71. PubMed ID: 14598660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recent topics on nonalcoholic steatohepatitis].
    Saibara T; Onishi S; enzan H
    Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):1104-9. PubMed ID: 12866461
    [No Abstract]   [Full Text] [Related]  

  • 31. Medical treatment of non-alcoholic steatohepatitis.
    Kadayifci A; Merriman RB; Bass NM
    Clin Liver Dis; 2007 Feb; 11(1):119-40, ix. PubMed ID: 17544975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity.
    Stratopoulos C; Papakonstantinou A; Terzis I; Spiliadi C; Dimitriades G; Komesidou V; Kitsanta P; Argyrakos T; Hadjiyannakis E
    Obes Surg; 2005 Sep; 15(8):1154-60. PubMed ID: 16197789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.
    Javor ED; Ghany MG; Cochran EK; Oral EA; DePaoli AM; Premkumar A; Kleiner DE; Gorden P
    Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of protein tyrosine phosphatase 1B and insulin receptor immunostains to differentiate nonalcoholic from alcoholic steatohepatitis in liver biopsy specimens.
    Sanderson SO; Smyrk TC
    Am J Clin Pathol; 2005 Apr; 123(4):503-9. PubMed ID: 15743753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutrition in pathophysiology and treatment of nonalcoholic fatty liver disease.
    Moschen AR; Tilg H
    Curr Opin Clin Nutr Metab Care; 2008 Sep; 11(5):620-5. PubMed ID: 18685459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonalcoholic fatty liver disease.
    Adams LA; Angulo P; Lindor KD
    CMAJ; 2005 Mar; 172(7):899-905. PubMed ID: 15795412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alcoholic and nonalcoholic forms of fatty liver disease.
    Forgione A; Miele L; Cefalo C; Gasbarrini G; Grieco A
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):83-100. PubMed ID: 17415346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel treatment modalities for nonalcoholic steatohepatitis.
    Satapathy SK; Sanyal AJ
    Trends Endocrinol Metab; 2010 Nov; 21(11):668-75. PubMed ID: 20880717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).
    Ali R; Cusi K
    Ann Med; 2009; 41(4):265-78. PubMed ID: 19353360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.